Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,351 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,351 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,351 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,351 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,351 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,351 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,351 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Nov 2025
Lawrence D Kingsley Director · indirect
Sold at will
$7.15M 300,000 at 23.83
7.1%
Not planned
21 Nov 2025
Alexander C. Karp See Remarks
Sold at will 3×
$7.12M 45,564 at 156.25
0.7%
Not planned
21 Nov 2025
Stephen Andrew Cohen See Remarks
Sold at will 3×
$6.12M 39,136 at 156.25
98.5%
Sold half or more
21 Nov 2025
Keith Rupert Murdoch Chairman Emeritus · indirect
Sold at will
$5.93M 100,000 at 59.26
8.3%
Not planned
21 Nov 2025
William Monteleone President and CEO
Sold at will 2×
$4.28M 99,284 at 43.15
19.0%
Not planned
21 Nov 2025
Ernie Herrman CEO & President
Sold at will
$3.69M 24,363 at 151.31
4.6%
Not planned
21 Nov 2025
Lei Zhang Schlitz VP & Pres, Global Products
Sold at will
$3.63M 32,031 at 113.20
32.4%
Not planned
21 Nov 2025
Randal J Kirk Director · indirect
Sold at will
$3.59M 937,308 at 3.83
14.4%
Not planned
21 Nov 2025
Joanne C. Crevoiserat Chief Executive Officer
Sold at will
$3.34M 31,735 at 105.31
4.5%
Not planned
21 Nov 2025
Sold at will
$3.26M 171,800 at 19.00
49.8%
Not planned
21 Nov 2025
Sold at will
$3.16M 29,451 at 107.41
27.0%
Not planned
21 Nov 2025
J Patrick Doyle Executive Chairman
Sold at will 3×
$3.04M 43,597 at 69.80
18.4%
Not planned
21 Nov 2025
Shyam Sankar See Remarks
Sold at will 3×
$2.97M 19,004 at 156.25
2.9%
Not planned
21 Nov 2025
Christos Dimopoulos Executive VP, Global Markets
Sold at will 2×
$2.39M 25,300 at 94.37
19.5%
Not planned
21 Nov 2025
Fred P. Lampropoulos Executive Chairman
Sold at will
$2.18M 25,000 at 87.31
2.4%
Not planned
21 Nov 2025
Marshall S. Stanton SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
21 Nov 2025
Scott A. Roe CFO and COO
Sold at will
$1.97M 18,794 at 104.85
11.3%
Not planned
21 Nov 2025
Kevin M. Brady CFO & Treasurer
Sold at will
$1.77M 3,000 at 590.35
33.3%
Not planned
21 Nov 2025
Jason W. Fraser EVP & CFO
Sold at will
$1.73M 9,933 at 174.02
6.9%
Not planned
21 Nov 2025
Sold at will 5×
$1.69M 45,715 at 37.05
88.6%
Sold half or more
21 Nov 2025
John Swieringa Pres, Tech & COO
Sold at will
$1.48M 22,000 at 67.34
7.2%
Not planned
21 Nov 2025
David Donnay Rowland EVP & Co-Chief Invest. Officer
Sold at will
$1.45M 5,000 at 290.57
22.2%
Not planned
21 Nov 2025
Jeff B Gustavson Vice President
Sold at will
$1.40M 9,325 at 150.27
84.8%
Sold half or more
21 Nov 2025
Julia Madsen Sr. VP and GM, Life Sciences
Sold at will 2×
$1.31M 5,008 at 262.00
31.9%
Not planned
21 Nov 2025
Levesque Rati Sahi Chief Executive Officer
Sold at will 5×
$1.27M 97,036 at 13.06
5.7%
Not planned
21 Nov 2025
Patrick J. Haley EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
21 Nov 2025
Amy D. Husted Exec VP General Counsel & Sec
Sold at will
$1.12M 10,413 at 107.42
47.0%
Not planned
21 Nov 2025
Hayden Brown President & CEO
Sold at will
$1.09M 60,000 at 18.20
5.4%
Not planned
21 Nov 2025
Sold at will
$1.09M 20,000 at 54.52
16.9%
Not planned
21 Nov 2025
Jenele C Grassle Director
Sold at will
$1.01M 2,400 at 420.87
49.0%
Not planned
21 Nov 2025
Ali John Mirshekari Director · indirect
Sold at will
$1.00M 33,933 at 29.53
100%
Sold half or more
21 Nov 2025
Ignacio A Cortina EVP, CL&AO & Secretary
Sold at will
$995.28K 8,000 at 124.41
15.0%
Not planned
21 Nov 2025
Ra Capital Management, L.p. Director · indirect
Sold at will 4×
$994.73K 25,183 at 39.50
13.7%
Not planned
21 Nov 2025
Helga Houston Senior Exec. V. P.
Sold at will
$993.35K 64,587 at 15.38
10.8%
Not planned
21 Nov 2025
John M Heyneman Jr Director · indirect
Sold at will
$944.30K 30,432 at 31.03
2.1%
Not planned
21 Nov 2025
Erke Huang Chief Financial Officer
Sold at will
$825.38K 410,636 at 2.01
25.9%
Not planned
21 Nov 2025
David Fisher Chief Executive Officer
Sold at will
$745.53K 6,000 at 124.25
1.7%
Not planned
21 Nov 2025
Donald A Colvin Director
Sold at will
$739.68K 6,000 at 123.28
19.6%
Not planned
21 Nov 2025
Kang Sun Chief Executive Officer
Sold at will
$692.13K 68,655 at 10.08
4.7%
Not planned
21 Nov 2025
James Pursley President
Sold at will 3×
$683.49K 15,000 at 45.57
1.9%
Not planned
21 Nov 2025
Robert Francis Sharpe JR Director · indirect
Sold at will
$676.42K 1,500 at 450.95
16.7%
Not planned
21 Nov 2025
Owen Britton Jennings Business Lead
Sold at will
$639.60K 10,417 at 61.40
4.1%
Not planned
21 Nov 2025
John S. Anderson Senior Vice President & CFO
Sold at will 3×
$632.00K 30,000 at 21.07
12.1%
Not planned
21 Nov 2025
Amrita Ahuja CFO & COO
Sold at will
$611.48K 9,959 at 61.40
3.5%
Not planned
21 Nov 2025
Frederick W. McTaggart President and CEO
Sold at will
$608.09K 18,152 at 33.50
6.3%
Not planned
21 Nov 2025
William H Heyman Vice Chairman
Sold at will 2×
$583.00K 2,000 at 291.50
0.8%
Not planned
21 Nov 2025
Dunson K Cheng Executive Chairman
Sold at will
$478.52K 10,000 at 47.85
6.4%
Not planned
21 Nov 2025
Sylebra Capital LLC See Footnotes · indirect
Sold at will
$472.43K 3,046 at 155.10
0.2%
Not planned
21 Nov 2025
Katherine Patricia Clune Chief Financial Officer
Sold at will
$443.85K 1,367 at 324.69
11.6%
Not planned
21 Nov 2025
Arnaud Weber Engineering Lead
Sold at will
$435.63K 7,095 at 61.40
2.7%
Not planned
Showing 21,951–22,000 of 23,351. ← Newer Page 440 of 468 Older →